Officials say that ‘streamlining’ targets will help deliver faster treatment for hundreds of thousands of patients – but ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

The City of London Corporation's Planning and Transportation Committee has given the green light to new sustainability ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

The ADG warns of a gap in the dental workforce as it awaits the Labour government and DHSC’s action plan to deliver on ...

Currently, registration is open for most European venues - Paris, London, Milan, Berlin - with other Madrid, Amsterdam, and venues in other territories to follow. What's perhaps most notable is ...

Lord Darzi’s recent report highlighted a myriad of problems for the NHS but also plenty of solutions, one of them being a “tilt towards technology”. An HSJ webinar, in association with Juniper ...

Credit: Scharfsinn via Shutterstock. The UK’s National Health Service Shared Business Services (NHS SBS) has announced a £500m ($514m) framework agreement to assist domestic public sector ...

Artificial intelligence (AI) profit-makers look set to get their hands on NHS data. And lobbying Labour Friends of Israel vice chair Peter Kyle probably played a role. the health service is set ...

The prime minister said a new agreement has been signed with the private sector to "make the spaces, the facilities and resources of private hospitals more readily available to the NHS".

More NHS hubs will be set up in community locations and there will be greater use of the private sector to help reduce hospital waiting lists in England, the prime minister has said. Sir Keir ...

Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY - - Agreement for CASGEVY in transfusion-dependent beta thalassemia (TDT) was previously reached ...